Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels
- PMID: 2517295
- DOI: 10.1007/BF01139184
Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels
Abstract
Fifteen women with normal basal gonadotropin levels and adequate responses to conventional gonadotropin stimulation for in vitro fertilization (IVF) were pretreated with leuprolide acetate (LA) beginning in the midluteal phase prior to a repeat IVF attempt. A significantly longer duration of stimulation requiring a significantly higher total dosage of gonadotropins was observed in LA cycles. The number of preovulatory oocytes retrieved and preembryos transferred was significantly higher in LA cycles. Six of 15 women (40%) had cryopreservation of supernumerary preembryos in LA cycles, versus none in non-LA cycles; 22% of preovulatory oocytes aspirated in LA cycles were available for cryopreservation for future transfer. Five pregnancies occurred in the 15 LA cycles. IVF patients with normal basal gonadotropin levels and normal responses to conventional gonadotropin stimulation benefit from LA pretreatment.
Similar articles
-
Follicular development and oocyte maturation after stimulation with gonadotropins versus leuprolide acetate/gonadotropins during in vitro fertilization.Fertil Steril. 1990 Oct;54(4):656-60. doi: 10.1016/s0015-0282(16)53825-4. Fertil Steril. 1990. PMID: 2120086
-
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.Fertil Steril. 1989 Feb;51(2):292-7. doi: 10.1016/s0015-0282(16)60493-4. Fertil Steril. 1989. PMID: 2492234 Clinical Trial.
-
Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.Fertil Steril. 1990 Feb;53(2):302-5. doi: 10.1016/s0015-0282(16)53285-3. Fertil Steril. 1990. PMID: 2105247 Clinical Trial.
-
Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success.Fertil Steril. 1991 Sep;56(3):500-4. doi: 10.1016/s0015-0282(16)54548-8. Fertil Steril. 1991. PMID: 1909977
-
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359. Hum Reprod. 1997. PMID: 9436663
Cited by
-
Animal models of transcranial direct current stimulation: Methods and mechanisms.Clin Neurophysiol. 2016 Nov;127(11):3425-3454. doi: 10.1016/j.clinph.2016.08.016. Epub 2016 Sep 10. Clin Neurophysiol. 2016. PMID: 27693941 Free PMC article. Review.
-
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.Drugs. 1994 Dec;48(6):930-67. doi: 10.2165/00003495-199448060-00008. Drugs. 1994. PMID: 7533699 Review.
-
Treatment of low responders.J Assist Reprod Genet. 1993 Feb;10(2):112-4. doi: 10.1007/BF01207730. J Assist Reprod Genet. 1993. PMID: 8339011 Review. No abstract available.